Sprout investors say Valeant prices 'female Viagra' too high - Bloomberg
March 25 (Reuters) - Investors in Sprout Pharmaceuticals, which makes the first drug to treat low sexual desire in women and was bought by Valeant Pharmaceuticals International Inc last year, say the...
No comments:
Post a Comment